SURGIBRIM® (Brimonidine tartrate 0.2%) is a sterile ophthalmic solution. SURGIBRIM® is used for reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma or ocular hypertension. As monotherapy in patients in whom topical beta-blocker therapy is contraindicated and as adjunctive therapy to other intraocular pressure lowering medications when the target intraocular pressure is not achieved with a single agent.
Adults including the elderly: One drop into the affected eye(s) twice daily, approximately 12 hours apart. No dosage adjustment is required in elderly patients. To reduce possible systemic absorption, it is recommended that the lacrimal sac be compressed at the medial canthus (punctal occlusion) for one minute immediately after the instillation of each drop. The safety and efficacy of brimonidine has not been established in children. If more than one topical ophthalmic drug is to be administered, they should be instilled 5 to 15 minutes apart.
SURGIBRIM® (brimonidine ophthalmic solution) 0.2% is supplied sterile in opaque white LDPE plastic bottle with dropper with purple high impact polystyrene (HIPS) cap in 5ml pack.